Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe (Positioning the Veneto Region at the core of global and European health policies, 3-4 December 2015, Scuola San Giovanni Evangelista, Venice, Italy)
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the Advanced Training and Conference on Health Economics (24 June 2015, Budapest, Hungary)
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the School of Public Health Management (Chisinau, Republic of Moldova, 24 November 2016)
Contemporary health policy context in Europe: some opportunities and challenges
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe. 8 March 2017, Israel
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe (Positioning the Veneto Region at the core of global and European health policies, 3-4 December 2015, Scuola San Giovanni Evangelista, Venice, Italy)
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the Advanced Training and Conference on Health Economics (24 June 2015, Budapest, Hungary)
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the School of Public Health Management (Chisinau, Republic of Moldova, 24 November 2016)
Contemporary health policy context in Europe: some opportunities and challenges
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe. 8 March 2017, Israel
Presentation delivered by Zsuzsanna Jakab, WHO Regional Director for Europe, at the Meeting of the European Environment and Health Ministerial Board (24 February 2015, Madrid, Spain)
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 21st Congress of the European Association of Dental Public Health (1 October 2016 Budapest)
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizens’ Health", on 5 March 2014, Athens, Greece.
This presentation is part of the report presented by the WHO Regional Director Zsuzsanna Jakab at the 63rd session of the WHO Regional Committee for Europe in Çeşme Izmir, Turkey, on 16 September 2013.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 67th session of the WHO Regional Committee for Europe (Budapest, Hungary, 11–14 September 2017)
Presentation by Dr Zsuzsanna Jakab,WHO Regional Director for Europe, at the Third High-level Meeting of the Small Countries Initiative, in Monaco, on 11–12 October 2016
This third edition of Health at a Glance: Europe presents key indicators of health and health systems in the 28 European Union member states, four candidate countries and three EFTA countries. The selection of indicators is based largely on the European Core Health Indicators (ECHI), a set of indicators that has been developed to guide the reporting of health statistics in the European Union. This is complemented by additional indicators on quality of care, access to care and health expenditure, building on the OECD expertise in these areas.
Compared with the previous edition, this third edition includes a greater number of ECHI indicators. It also includes a new chapter on access to care, including indicators related to financial access, geographic access and timely access.
Dr Zsuzsanna Jakab, WHO Regional Director for Europe,Policy Dialogue on Health System and Public Health Reform in Cyprus: Health in the 21st Century, 26–27 September 2017, Nicosia, Cyprus
Presented by Dr Piroska Östlin, Director and Dr Santino Severoni, Coordinator, Public Health and Migration, Division of Policy and Governance for Health and Well-being, WHO/Europe, at the 66th session of the WHO Regional Committee for Europe.
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting on Interdepartmental Plan for Public Health of Catalonia (PINSAP) Strategy and Programme, held in Barcelona, Spain on 14 February 2014.
Presentation - Advancing health literacy and social mobilization for the United Nations 2030 Sustainable Development Goals
18 May 2017, Geneva, Switzerland
By Dr Zsuzsanna Jakab, WHO Regional Director for Europe
presented by Zsuzsanna Jakab, WHO Regional Director for Europe on 18 November 2014 at Ministerial Meeting in Skopje, The former Yugoslav Republic of Macedonia
Presentation delivered by Zsuzsanna Jakab, WHO Regional Director for Europe, at the Meeting of the European Environment and Health Ministerial Board (24 February 2015, Madrid, Spain)
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 21st Congress of the European Association of Dental Public Health (1 October 2016 Budapest)
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizens’ Health", on 5 March 2014, Athens, Greece.
This presentation is part of the report presented by the WHO Regional Director Zsuzsanna Jakab at the 63rd session of the WHO Regional Committee for Europe in Çeşme Izmir, Turkey, on 16 September 2013.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 67th session of the WHO Regional Committee for Europe (Budapest, Hungary, 11–14 September 2017)
Presentation by Dr Zsuzsanna Jakab,WHO Regional Director for Europe, at the Third High-level Meeting of the Small Countries Initiative, in Monaco, on 11–12 October 2016
This third edition of Health at a Glance: Europe presents key indicators of health and health systems in the 28 European Union member states, four candidate countries and three EFTA countries. The selection of indicators is based largely on the European Core Health Indicators (ECHI), a set of indicators that has been developed to guide the reporting of health statistics in the European Union. This is complemented by additional indicators on quality of care, access to care and health expenditure, building on the OECD expertise in these areas.
Compared with the previous edition, this third edition includes a greater number of ECHI indicators. It also includes a new chapter on access to care, including indicators related to financial access, geographic access and timely access.
Dr Zsuzsanna Jakab, WHO Regional Director for Europe,Policy Dialogue on Health System and Public Health Reform in Cyprus: Health in the 21st Century, 26–27 September 2017, Nicosia, Cyprus
Presented by Dr Piroska Östlin, Director and Dr Santino Severoni, Coordinator, Public Health and Migration, Division of Policy and Governance for Health and Well-being, WHO/Europe, at the 66th session of the WHO Regional Committee for Europe.
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting on Interdepartmental Plan for Public Health of Catalonia (PINSAP) Strategy and Programme, held in Barcelona, Spain on 14 February 2014.
Presentation - Advancing health literacy and social mobilization for the United Nations 2030 Sustainable Development Goals
18 May 2017, Geneva, Switzerland
By Dr Zsuzsanna Jakab, WHO Regional Director for Europe
presented by Zsuzsanna Jakab, WHO Regional Director for Europe on 18 November 2014 at Ministerial Meeting in Skopje, The former Yugoslav Republic of Macedonia
IPH Director of Research, Professor Kevin Balanda made a presentation entitled 'Some personal reflections on trans-disciplinary research for better population health & wellbeing' at the Irish Research Councils Horizon 2020 ‘Creative Connections’ workshop held on the 11 February 2014. He argued that comprehensive systems-wide solutions are needed to meet complex public health challenges and that these can only be supported by research that genuinely brings together the contributions of many disciplines and perspectives
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, on 3 September 2015, at briefing for Ambassadors in Copenhagen, Denmark
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 7th Meeting of the European Advisory Committee on Health Research (Copenhagen, Denmark, 6 April 2016)
Application of Clustering in Data Science using Real-life Examples Edureka!
Clustering data into subsets is an important task for many data science applications. It is considered as one of the most important unsupervised learning technique. Keeping this in mind, we have come with a free webinar ‘Application of Cluster in Data Science using Real-life examples.’
This presentation was made by at the 3rd Health Systems Joint Network meeting for Central, Eastern and South-eastern European Countries held in Vilnius, Lithuania, on 25-26 April 2019
This fourth edition of Health at a Glance: Europe presents key indicators of health and health systems in the 28 EU countries, 5 candidate countries to the EU and 3 EFTA countries. This 2016 edition contains two main new features: two thematic chapters analyse the links between population health and labour market outcomes, and the important challenge of strengthening primary care systems in European countries; and a new chapter on the resilience, efficiency and sustainability of health systems in Europe, in order to align the content of this publication more closely with the 2014 European Commission Communication on effective, accessible and resilient health systems. This publication is the result of a renewed collaboration between the OECD and the European Commission under the broader "State of Health in the EU" initiative, designed to support EU member states in their evidence-based policy making.
Structure and governance of financing - Tamas Evetovits, WHOOECD Governance
This presentation was made by Tamas Evetovits, WHO, at the 2nd Health Systems joint Network Meeting for Central, Eastern and Southeastern European Countries held in Tallinn, Estonia, on 1-2 December 2016
Presentation delivered by Dr Zsuzsanna Jakab, Regional Director WHO Europe, at the international health forum (Ashgabat, Turkmenistan, 21-22 July 2015)
This presentation was made by Tamas EVETOVITS, WHO Barcelona Office, at the 5th Meeting of the joint OECD DELSA/GOV Network on Fiscal Sustainability of Health Systems held on 4-5 February 2016 at the OECD Conference Centre in Paris.
DELSA/GOV 3rd Health meeting - Tamas EVETOVITSOECD Governance
This presentation by Tamas EVETOVITS was made at the 3rd Joint DELSA/GOV Health Meeting, Paris 24-25 April 2014. Find out more at www.oecd.org/gov/budgeting/3rdmeetingdelsagovnetworkfiscalsustainabilityofhealthsystems2014.htm
Budgeting for healthcare - Camila Vammalle, OECDOECD Governance
This presentation was made by Camila Vammalle, OECD, at the 11th Annual Meeting of Central, Eastern and South-Eastern Senior Budget Officials (CESEE SBO) held in Warsaw, Poland, on 21-22 May 2015.
Presentation on epi data during the conference "New challenges and unmet needs of children and adolescents living and ageing with HIV/AIDS", 19-22 January 2017, Bucharest, Romania
The following slides provide the background data and information that have informed the future trends identified under the health theme. This presentation should be viewed alongside those for the other themes in order for the wider picture to be understood.
Reported measles cases for the period November 2020—October 2021 (data as of 02 December 2021).A monthly summary of the epidemiological data on selected vaccine-preventable diseases in the WHO European Region
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Antimicrobial stewardship to prevent antimicrobial resistanceGovindRankawat1
India is among the nations with the highest burden of bacterial infections.
India is one of the largest consumers of antibiotics worldwide.
India carries one of the largest burdens of drug‑resistant pathogens worldwide.
Highest burden of multidrug‑resistant tuberculosis,
Alarmingly high resistance among Gram‑negative and Gram‑positive bacteria even to newer antimicrobials such as carbapenems.
NDM‑1 ( New Delhi Metallo Beta lactamase 1, an enzyme which inactivates majority of Beta lactam antibiotics including carbapenems) was reported in 2008
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
1. Health 2020 and
health systems
strengthening
Dr Zsuzsanna Jakab
Regional Director
WHO Regional Office for Europe
Ljubljana, Slovenia, 30 October 2015
2. Contents
From the Ljubljana Charter to Health 2020
Health situation in Slovenia
Investing in health
Slovenia health system review
Refugee and migrant health
Preparedness and response (Ebola)
Content
4. Ljubljana charter
Driven by values
Targeted on health
Oriented towards primary care
Based on sound financing
Centred on people
5. Alma-Ata Declaration;
Ljubljana Conference on
Reforming Health Care
1978-96
Introduced core health system functions:
governance; services delivery; financing;
resource generation
2000
Tallinn Charter:
health systems
for health and wealth
2008 and 2013
Oslo conference:
Impact of crisis
2009 & 2013
2012
Health 2020 priority area:
strengthening people-centred
health systems and public health
From the Ljubljana Charter to Health 2020
6. New vision for health systems strengthening
reaches out to people
8. Two important measures for
universal health care
Unmet
need
Financial
protection
against the costs
of ill health
9. Slovenia is a top performer in
universal health care
Unmet need for a medical examination for financial or other reasons by
income group in the European Union, EU-SILC data for 2012
10. Financial protection is excellent: out-of-pocket
payment <15%
Out-of=pocket payment as a share (%) of total expenditure on health
ranked from low to high by income (high, upper-middle, lower-middle, low)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
Netherlands
Monaco
France
UK
Luxembourg
Slovenia
Germany
SanMarino
Denmark
Norway
Croatia
CzechRepublic
Ireland
Austria
Sweden
Andorra
Iceland
Estonia
Finland
Belgium
Italy
Spain
Poland
Slovakia
Israel
Hungary
Switzerland
Lithuania
Greece
Portugal
Malta
RussianFederation
Latvia
Bulgaria
Cyprus
Turkey
Belarus
Romania
BosniaandHerzegovina
TFYRM
Montenegro
Turkmenistan
Serbia
Kazakhstan
Albania
Azerbaijan
Kyrgyzstan
Ukraine
Uzbekistan
RepublicofMoldova
Armenia
Georgia
Tajikistan
Source: WHO Global Health Expenditure Database for 2011
Alarming zone
12. The share of public expenditure for health spending is
lower in Slovenia than in many comparable countries
IE
NL
HU
AT
HR
SK
EE
CZ
FI
DE
WHO Europe: European Health for All database
60
65
70
75
80
85
90
95
1995 2000 2005 2010
EU15
SI
EU13
WHO/Europe
% of all health expenditure
13. Total health expenditure (as % of GDP) is
lower in Slovenia than the EU15 average
IE
NL
HU
AT
HR
SK
EE
CZ
FI
DE
WHO Europe: European Health for All database
4
5
6
7
8
9
10
11
12
13
1995 2000 2005 2010
EU15
SI
EU13
WHO/Europe
% GDP
14. 60
65
70
75
80
85
Life expectancy is increasing and the gap
between Slovenia and EU15 is closing!
EU15
SI
EU13
WHO/Europe
DE
1980 1990 2000 2010
60
65
70
75
80
85
IENL
HU
AT
HR
SK
EE
FI
CZ
1980 1990 2000 2010
years years
males females
NL
FI
EE
HUAT
CZIE
HR
WHO Europe: European Health for All database
17. Gap in life expectancy at 30 years of
age by education level, Slovenia, 2010
18. East–west: gap in mortality
Mortality due to circulatory
system diseases
Source: National Institute of Public Health
19. High impact of mother‘s level of education
on stillbirths and perinatal mortality
Source:NationalInstituteofPublicHealth
20. The Region is on track to reducing premature mortality
Maximum
value
Regional
average
Minimum
value
21. Premature mortality in Slovenia is
decreasing
EU15
SI
EU13
WHO/Europe
1980 1990 2000 2010
100
200
300
400
500
600
700
IE
NL
HU
AT
HR
SK
EE
CZ
FI
DE
age-standardized death rate - all causes, 0-64, per 100000
WHO Europe: European Health for All database
22. litres of pure alcohol are
drunk per person per year
of the population is
overweight or obese
of the population
uses tobacco
23. Alcohol consumption remains a problem.
IE
NL
HU
ATHR
SK
EE
CZ
FI
1980 1990 2000 2010
5
7
9
11
13
15
17
19 EU15
SI
EU13
WHO/Europe
DE
Pure alcohol consumption, litres per capita, age 15+
WHO Europe: European Health for All database
25. 0%
5%
10%
15%
20%
25%
30%
35%
40%
čisto spodnji in
delavski sloj
srednji sloj višji srednji in
zgornji sloj
Delež(%)
TRENUTNI KADILCI
2001
2004
2008
2012
Comprehensive legislation on tobacco
control is needed.
Current smokers
Source: National Institute of Public Health
Lower social
class
Middle social
class
Higher/highest
social class
26. Noncommunicable diseases – by far the first cause of
mortality – are the key challenge in Slovenia
Source: WHO mortality database
With continued good
work in monitoring
communicable
diseases, work must
be strengthened in
all sectors working in
noncommunicable
diseases, especially
cancer, suicide and
injuries.
27. Acute respiratory
infections, pneumonia and
influenza in children <5y
Traffic accidents
Suicide
Cervical cancer
Breast cancer
Lung cancer
Cerebrovascular
disease
Heart disease
0 10 20 30 40
Standardized death rate per 100,000 population
EU13
EU15
European Region
Slovenia
Diseases that represent the highest burden
of premature mortality in Slovenia
Source: WHO Europe: Mortality indicator database.
Standardized premature
mortality (age 0–64 years)
due to selected diseases,
2010
28. The mortality rate from cancer is high,
and lung cancer is in the lead
EU15
SI
EU13
WHO/Europe
1980 1990 2000 2010
WHO Europe: European Health for All database
IE
NL
HU
AT
HR
SK
EE
CZ
FI
DE
130
150
170
190
210
230
250
270
290
age-standardized death rate – number of deaths per 100.000
29. Mortality from diseases of the circulatory system
has been effectively reduced in Slovenia
EU15
SI
EU13
WHO/Europe
1980 1990 2000 2010
IE
NL
HU
AT
HR
SK
EE
CZ
FI
DE
100
200
300
400
500
600
700
800
age-standardized death rate – number of deaths per 100.000
WHO Europe: European Health for All database
30. Slovenia has some of the best results in
reducing infant deaths
IE
NL
HU
AT
HR
SK
EE
CZFI
EU15
SI
EU13
WHO/Europe
1980 1990 2000 2010
Infant deaths per 1000 live births
0
5
10
15
20
25
DE
WHO Europe: European Health for All database
31. The percentage of the population ≥ 65 years
in Slovenia is rising rapidly.
8
10
12
14
16
18
20
22
SK
IE
HU
AT
EE
FI
NL
CZ
EU15
SI
EU13
WHO/Europe
DE
HR
1980 1990 2000 2010
% of population aged 65+ years
WHO Europe: European Health for All database
33. Health is an investment - not an expense:
we should invest more in health.
34. Health is a political choice.
64th session of the Regional Committee
for Europe, Denmark
35. European countries are strengthening their health
policies
.all answers (n=31 and 36 for 2010 and 2013, respectively)
No,butplanned forthefuture
Yes,anotherstrategy
Yes,comprehensivehealthpolicy
NationalhealthpolicyisalignedwithH2020
Allanswers(n=31and36for2010and2013,respectively)
2013
2010
Yes, comprehensive health
policy
Yes, another strategy
0% 10% 20% 30% 40% 50% 60% 70%
Noandnotplannedforthefuture
No,butplanned forthefuture
Yes,anotherstrategy
2013
2010
2013
2010
36. Health 2020: the right political choices for health
Increase
healthy life
expectancy
.
Enhance
well-
being
Reduce
inequity
Reduce
premature
mortality
Support
upstream
approaches to
governance
and
determinants
of health and
universal
health
coverage
Establish
national
targets in
health
policies, and
monitor
41. Slovenia’s health system – a collaborative
effort
Five technical
assistance
work
packages
Generating
evidence to
support process
in Slovenia
Collaboration
between WHO,
the European
Observatory and
more than 50
Slovene experts
42. Generating evidence
Five work packages covering a range of health system areas:
1. New, fully updated “Health systems in transition” profile
for Slovenia
2. Health system expenditure
3. Health system funding
4. Purchasing and payment
5. Optimizing service delivery
43. Benefits of a health system review
• Focus on the performance of the health system
• Provide detailed evidence on key challenges
• Identify areas amenable to reform
• Ensure consistency with Slovenia’s health
system values: sustainability, efficiency, equity
and quality
44. Health financing policy objectives and
performance
Financial protection
• Does use of health services cause
financial hardship?
Equity in financing
• Who bears the financial burden of
health services?
45. Adequate funding levels
Stable revenue flows
Administrative efficiency
Health financing policy objectives and
performance
46. Enhancing health system efficiency
• More efficient use of health resources is a pillar of
successful health system reform.
• Purchasing and payment functions must be well
designed and implemented.
• Health system review provides evidence on:
- the benefits of a health technology assessment
- strategic purchasing of goods and services
- equitable payment systems for health providers
47. Some indicators already show excellent
efficiency
IE
NL
HU
AT
HR
SK
EE
CZ
FI
DE
WHO Europe: European Health for All database
EU15
SI
EU13
WHO/Europe
Average length of stay in hospital – number of days
6
10
14
18
1980 1990 2000 2010
48. Admissions for inpatient care could be
reduced
IE
NL
HU
AT
HR
SKEE
CZ
FI
DE
WHO Europe: European Health for All database
EU15
SI
EU13
WHO/Europe
In-patient care admissions per 100
9
12
15
18
21
24
27
30
1980 1990 2000 2010
50. Density of doctors
IE
NL
HU
AT
HR
SK EE
CZ
FI
1980 1990 2000 2010
Source: European database on human and technical resources for health.
200
250
300
350
400
450
500
EU15
SI
EU13
WHO/Europe
DE
Physicians per 100000
51. Density of nurses
IE
NL
HU
AT
HR
SK
EE
CZ
FI
DE
1990 2000 2010
EU15
SI
EU13
WHO/Europe
Nurses (PP) per 100000
400
500
600
700
800
900
1000
1100
1200
1300
1400
European database on human and technical resources for health.
52. Ensuring effective service delivery
The health system review explores opportunities to
optimize the delivery of health services, including:
- building on model family medical practices to meet the
needs of people with chronic and multiple conditions
- supporting coordination and decision-making between
levels of care
- moving care out of hospitals when appropriate
- strengthening information technology
- model practices = referenčne ambulante
53. Evidence-based policy-making
The health system review highlights Slovenia’s
commitment to evidence-based policy-making.
A basis for further discussion and consensus-
building on priorities for health system reform
Continued support from WHO
55. Refugee and migrant health, a challenge
for the WHO European Region
1 out of 12 residents is a migrant
77 million migrants are living in the WHO European Region, which
represent 8% of its population.
Ensuring adequate standards of care for
refugees and migrants is essential:
For population health.
For the protection and promotion of
human rights of refugees, migrants and
the resident population.
This is aligned with the fundamental
values of Health 2020, such as health
as a human right, solidarity and
protection of the vulnerable.
Almost 600,000 refugees and migrants have crossed the
Mediterranean in 2015 so far.
Increase of arrivals in Slovenia, with peaks of over
10,000 migrants entering on daily basis.
56. Demystifying refugee and migrant health
There is no systematic
association between
migration and the
importation of infectious
diseases.
57. The public health aspects of migration are influenced by policies
and interventions run by stakeholders outside the health sector,
which do not always take into account the health implications of
their actions.
Ministry
of Interior
Ministry
of Labour
Ministry of
Social
Affairs
Ministry of
Foreign
Affairs
Ministry of
Education
Ministry of
Health
Refugee and migrant health,
a multisectoral agenda
58. Adapting to diversity: towards migrant-
sensitive health systems
Refugees/migrants = heterogeneous group
need to respond to diverse health
needs:
Sexual reproductive health and
rights
Mother and child health
Diabetes
Cardiovascular diseases
Mental health
Emergency care and protection
Protection against vaccine-
preventable diseases
59. 2015 Goal: achieve zero human-to-human Ebola transmission
• The outbreak is not over: sporadic cases still reported in Guinea:
3 new confirmed cases reported in the week of 18 October.
• Robust surveillance remains essential..
• Vaccination trial continuing in Guinea; positive outcome, may play
a key role in ending the outbreak.
2016 Goal: sustain a resilient zero by rapidly detecting & stopping
new emergences
Ebola situation as of 21 October 2015
60. A unified
WHO
programme
for outbreaks
and
emergencies
Priority to
core
capacities of
the
International
Health
Regulations
A global
health
emergency
workforce
Improved
functioning,
transparency,
effectiveness
and
efficiency
of
International
Health
Regulations
Accelerated
research and
development
in epidemics
or health
emergencies
WHO
Contingency
Fund for
Emergencies
Reform of WHO’s Work in Outbreaks and Emergencies
with Health and Humanitarian Consequences
61. Overseen by WHO Director General, supported by:
– An Advisory Group on Reform of WHO’s Work in Outbreaks and
Emergencies with Health and Humanitarian consequences
• 19 high-level experts in large-scale emergency response, disaster preparedness, disease
outbreak control and crisis coordination. Chaired by UNSG SE on Ebola, David Nabarro. .
– A Project Team at WHO
Fed by other processes such as:
– An IHR Review Committee on the Role of the IHR(2005) in the Ebola
Outbreak and Response
• 16 experts from the IHR Roster of Experts. Chaired by Pr. Didier Houssin
Reform of WHO’s Work in Outbreaks and Emergencies
with Health and Humanitarian Consequences